Current Science

Open Access Open Access  Restricted Access Subscription Access

Mephedrone - An Emerging Drug of Abuse in India


Affiliations
1 Department of Forensic Science, Punjabi University, Patiala 147 002, India
 

Mephedrone (MEPH) is a synthetic derivative of cathinone, an alkaloid extracted from plant khat. Developed countries like UK, USA, Australia and Israel are the main places of MEPH abuse. Abuse of cathinone and MEPH in India has started recently. The young generation in metropolitan cities like Delhi, Mumbai, Ahmedabad and Panaji is being affected by its abuse. The increasing misuse of MEPH in India was due to its non-inclusion in the Narcotics Drugs and Psychotropic Substances (NDPS) Act, 1985 earlier. Due to the threat of MEPH abuse in the country, the Government of India included it in the NDPS Act from February 2015. Since then, the law enforcement agencies have taken strict action against MEPH users and traffickers.

In India, new drugs are rapidly emerging in the market and posing challenges for forensic toxicologists and law enforcement agencies. The seized drugs, urine and blood samples of the abusers are sent to forensic science laboratories for analysis. These samples are first screened by thin-layer chromatography, and then the confirmation and quantitation are done using modern instrumental methods. However, no studies are available in the literature on drug detection in saliva, sweat and other biological materials. Therefore a suitable technique needs to be developed for its detection in biological matrices. Particularly so for a country like India, this drug abuse is constantly increasing. In this article, we deal with the chemistry, pharmodynamics, drug-herb interaction, metabolic fate (pharmokinetics), related fatalities, abuse, effects and detection methods of MEPH, to create awareness about this drug abuse in India.


Keywords

Drug Abuse, Mephedrone, Synthetic Cathinone, Traffickers.
User
Notifications
Font Size

  • Kelly, J. P., Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test. Anal., 2011, 3, 439–453.

  • Matthews, A. and Bruno, R., Mephedrone use among regular ecstasy consumers in Australia. Ecstasy Rel. Drug Trends Bull., Sydney, 2010.

  • Drug Enforcement Administration, Office of Diversion Control, Drug & Chemical Evaluation Section, Khat, 2013; http://www.deadiversion.usdoj.gov/drug_chem_info/khat.pdf (accessed on 26 February 2016).

  • Sporkert, F., Pragst, F., Bachus, R., Masuhr, F. and Harms, L., Determination of cathinone, cathine and norephedrine in hair of Yemenite khat chewers. Forensic Sci. Int., 2003, 133, 39–46.

  • US Department of Justice, National Drug Intelligence Center. Situation report: synthetic cathinones (bath salts) – an emerging domestic threat. Johnstown, Pennsylvania, 2011; http://www.justice.gov/archive/ndic/pubs44/44571/44571p.pdf (accessed on 2 October 2016).

  • European Monitoring Centre for Drugs and Drug Addiction, Europol– EMCDDA joint report on a new psychoactive substance: 4methylmethcathinone (mephedrone). EMCDDA, Lisbon, 2010; http://www.emcdda.europa.eu/html.cfm/index132196EN.html (accessed on 2 October 2016).

  • Miottoa, K., Striebel, J., Chob, A. K. and Wanga, C., Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports. Drug Alcohol Depend., 2013, 132, 1–12.

  • Marinetti, L. J. and Antonides, H. M., Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal. Toxicol., 2013, 37, 135–146.

  • Psychonaut Web Mapping Research Group, Mephedrone report. Institute of Psychiatry, King’s College, London, UK, 2009.

  • Zawilska, J. B. and Wojcieszak, J., Designer cathinones – an emerging class of novel recreational drugs. Forensic Sci. Int., 2013, 231, 42–53.

  • The Australian Drug Foundation, Report, ‘mephedrone’, Melbourne, Australia, 2015.

  • Kihara, R. and Day, E., Transient psychotic episodes following recreational use of NRG-3. Prog. Neurol. Psychiatry., 2014, 18, 14–18.

  • The Indian Express, Maharashtra: Police register first case of ‘meow meow’ possession under NDPS Act. 25 February 2015; http://www.mid-day.com/articles/maharashtra-police-register-first-case-of-meow-meow-possession-under-ndps-act/16018161 (accessed on 2 October 2016).

  • Winder, G. S., Stern, N. and Hosanagar, A., Are ‘bath salts’ the next generation of stimulant abuse? J. Subst. Abuse Treat., 2013, 44, 42–45.

  • Meyer, M. R., Wilhelm, J., Peters, F. T. and Maurer, H. H., Beta keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry. Anal. Bioanal. Chem., 2010, 397, 1225–1233.

  • Ranjan, R., Gnanavel, S. and Sagar, R., Designer drugs: an overview and challenges in Indian drug abuse scenario. Delhi Psychiatry J., 2015, 18, 177–183.

  • Gibbons, S. and Zloh, M., An analysis of the ‘legal high’ mephedrone. Bioorg. Med. Chem. Lett., 2010, 20, 4135–4139.

  • Maskell, P. D., Paoli, G. D., Seneviratne, C. and Pounder, D. J., Mephedrone (4-methylmethcathinone) – related deaths. J. Anal. Toxicol., 2011, 35, 188–191.

  • http://cbn.nic.in/html/Mephedrone.pdf

  • Kehr, J., Ichinose, F., Yoshitake, S., Goiny, M., Sievertsson, T., Nyberg, F. and Yoshitake, T., Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br. J. Pharmacol., 2011, 164, 1949–1958.

  • Capriola, M., Synthetic cathinone abuse. Clin. Pharmacol., 2013, 5, 109–115.

  • http://www.itmonline.org/arts/herbdrug.htm (last accessed on 20 September 2016).

  • Green, A. R., King, M. V., Shortall, S. E. and Fone, K. C. F., The preclinical pharmacology of mephedrone; not just MDMA by another name. Br. J. Pharmacol., 2014, 171, 2251–2268.

  • Carhart-Harris, R. L., King, L. A. and Nutt, D. J., A web-based survey on mephedrone. Drug Alcohol Depend., 2011, 118, 19–22.

  • Moore, K., Dargan, P. I., Wood, D. M. and Measham, F., Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine. Eur. Addict. Res., 2013, 19, 276–282.

  • Hentig, N. V., Potential drug interactions between cART and new psychoactive substances. J. Antivir. Antiretrovir., 2016, 8, LXIV–LXVIII.

  • Angoa-Perez, M., Kane, M. J., Briggs, D. I., Francescutti, D. M., Sykes, C. E. and Shah, M. M., Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. J. Neurochem., 2013, 125, 102–110.

  • Shortall, S. E., Byatt, S., Kaufman, N., Lipman, H., Smith, G. and Green, A. R., Caffeine alters the behavioural and thermoregulatory responses to mephedrone without causing long-term neurotoxicity. J. Psychopharmacol., 2013, 27, A63.

  • Cameron, K., Kolanos, R., Verkariya, R., De Felice, L. and Glennon, R. A., Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of ‘bath salts’, produce opposite effects at the human dopamine transporter. Psychopharmacology, 2013, 227, 493–499.

  • Stahl, S. M., Pradko, J. F., Haight, B. R., Modell, J. G., Rockett, C. B. and Coughlin, S., A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Primary Care Companion J. Clin. Psychiatry, 2004, 6, 159–166.

  • Richmond, R. and Zwar, N., Review of bupropion for smoking cessation. Drug Alcohol Rev., 2003, 22, 203–220.

  • Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W. and Beckson, M., A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend., 1995, 40, 125–131.

  • Juffry, J. O., Pinnel, T., Patel, N., Bevin, M., Meintel, M. and Davidson, C., Stimulant mechanisms of cathinones – effects of mephedrone and other cathinones on basal and electrically evoked dopamine efflux in rat accumbens brain slices. Prog. Neuropsy-chopharmacol. Biol. Psychiatry, 2014, 54, 122–130.

  • Moody, D. E., Ruangyuttikarn, W. and Law, M. Y., Quinidine inhibits in vivo metabolism of amphetamine in rats: impact upon correlation between GCIMS and immunoassay findings in rat urine. J. Anal. Toxicol., 1990, 14, 311–317.

  • Farre, M. et al., Interactions between mephedrone and alcohol in humans: cardiovascular and subjective effects. Eur. Psychiatry, 2016, 33, S115.

  • Baumann, M. H., Partilla, J. S. and Lehner, K. R., Psychoactive ‘bath salts’: not so soothing. Eur. J. Pharmacol., 2013, 698, 1–5.

  • Hadlock, G. C. et al., 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J. Pharmacol. Exp. Ther., 2011, 339, 530–536.

  • Hargreaves, N. D., Holder, H., Ottoson, P. E. and Williams, T., Mephedrone: Public health risk, mechanisms of action, and behavioral effects. Eur. J. Pharmacol., 2013, 714, 1–3.

  • Saha, K. et al., Second-Generation’ Mephedrone Analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function. Neuropsychopharmacology, 2015, 40, 1321–1331.

  • Schifano, F., Albanese, A., Fergus, S., Stair, J. L., Deluca, P. and Corazza, O., Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues. Psychopharmacology, 2011, 214, 593–602.

  • Baumann, M. H., Ayestas, M. A., Partilla, J. S., Sink, J. R., Shulgin, A. T. and Daley, P. F., The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology, 2011, 37, 1192–1203.

  • Baumann, M. H., Partilla, J. S., Lehner, K. R., Thorndike, E. B., Hoffman, A. F. and Holy, M., Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology, 2013, 38, 552–562.

  • Gregg, R. A., Tallarida, C. S., Reitz, A., McCurdy, C. and Rawls, S. M., Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats. Drug Alcohol Depend., 2013, 133, 746–750.

  • Maurer, H. H., Chemistry, pharmacology, and metabolism of emerging drugs of abuse. Ther. Drug Monit., 2010, 32, 544–549.

  • Adamowicz, P., Tokarczyk, B., Stanaszek, R. and Slopianka, M., Fatal mephedrone intoxication – a case report. J. Anal. Toxicol., 2013, 37, 37–42.

  • Torrance, H. and Cooper, G., The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Forensic Sci. Int., 2010, 202, 62–63.

  • Dickson, A. J., Vorce, S. P., Levine, B. and Past, M. R., Case report; multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin. J. Anal. Toxicol., 2010, 34, 162–168.

  • Levy, A., Teenager dies after experimenting with legal drug meow meow; http://www.dailymail.co.uk/news/article-1245078/Teenagerdies-experimentinglegal-drug-meow-meow.html (accessed on 2 October 2016).

  • Rambabu, C., Rao, S. V., Ramu, G. and Babu, A. B., Quantitative analysis of mephedrone in bulk and pharmaceutical formulations by reverse phase high performance liquid chromatography. Rasayan J. Chem., 2010, 3, 796–799.

  • Camilleri, A., Johnston, M. R., Brennan, M., Davis, S. and David, G. E. C., Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoro-methamphetamine, a-phthalimidopropiophenone and N-ethyl-cathinone. Forensic Sci. Int., 2010, 197, 59–66.

  • Power, J. D., McGlynn, P., Clarke, K., McDermott, S. D., Kavanagh, P. and O’Brien, J., The analysis of substituted cathinones. Part 1: chemical analysis of 2-, 3- and 4-methylmethcathinone. Forensic Sci. Int., 2011, 212, 6–12.

  • Martin, M., Muller, J. F., Turner, K., Duez, M. and Cirimele, V., Evidence of mephedrone chronic abuse through hair analysis using GC/MS. Forensic Sci. Int., 2012, 218, 44–48.

  • Shaha, S. A. B., Deshmukh, N. I. K., Barkera, J., Petroczi, A., Cross, P., Archera, R. and Naughton, D. P., Quantitative analysis of mephedrone using liquid chromatography tandem mass spectroscopy: application to human hair. J. Pharm. Biomed., 2012, 61, 64–69.

  • Khreita, O. I. G., Irving, C., Schmidt, E., Parkinson, J. A., Daeid, N. N. and Sutcliffe, O. B., Synthesis, full chemical characterization and development of validated methods for the quantification of the components found in the evolved ‘legal high’ NRG-2. J. Pharm. Biomed., 2012, 61, 122–135.

  • Santali, E. Y., Cadogan, A. K., Daeid, N. N., Savage, K. A. and Sutcliffe, O. B., Synthesis, full chemical characterization and development of validated methods for the quantification of (±)-4-methylmethcathinone (mephedrone): a new ‘legal high’. J. Pharm. Biomed., 2011, 56, 246–255.

  • Verma, K. L., Madhulika, S. and Sarin, R. K., Analysis and detection of precursor chemicals used in preparation of narcotic drugs and psychotropic substances – a forensic perspective. J. Forensic Res., 2015, 6, 274.

  • Express News Service, Seized contraband was headed for Mumbai, 11 March 2015; http://indianexpress.com/article/cities/pune/seized-contraband-was-headed-for-mumbai/ (accessed on 2 October 2016).

  • Alok, R., The Indian Express. Another challenge for city police – youngsters addiction to ‘meow meow’, 29 December 2014; http://indianexpress.com/article/cities/mumbai/another-challenge-for-city-police-youngsters-addiction-to-meow-meow/2/ (accessed on 2 October 2016).

  • Kulkarni, S., The Indian Express, ‘Meow meow’ contraband seized on Expressway, 10 March 2015; http://indianexpress.com/article/cities/pune/meow-meow-contraband-seized-on-expressway/ (accessed on 2 October 2016).


Abstract Views: 315

PDF Views: 84




  • Mephedrone - An Emerging Drug of Abuse in India

Abstract Views: 315  |  PDF Views: 84

Authors

Ankush Laxman Rathod
Department of Forensic Science, Punjabi University, Patiala 147 002, India
Sandeep Singh Sahota
Department of Forensic Science, Punjabi University, Patiala 147 002, India
Rakesh Kumar Garg
Department of Forensic Science, Punjabi University, Patiala 147 002, India

Abstract


Mephedrone (MEPH) is a synthetic derivative of cathinone, an alkaloid extracted from plant khat. Developed countries like UK, USA, Australia and Israel are the main places of MEPH abuse. Abuse of cathinone and MEPH in India has started recently. The young generation in metropolitan cities like Delhi, Mumbai, Ahmedabad and Panaji is being affected by its abuse. The increasing misuse of MEPH in India was due to its non-inclusion in the Narcotics Drugs and Psychotropic Substances (NDPS) Act, 1985 earlier. Due to the threat of MEPH abuse in the country, the Government of India included it in the NDPS Act from February 2015. Since then, the law enforcement agencies have taken strict action against MEPH users and traffickers.

In India, new drugs are rapidly emerging in the market and posing challenges for forensic toxicologists and law enforcement agencies. The seized drugs, urine and blood samples of the abusers are sent to forensic science laboratories for analysis. These samples are first screened by thin-layer chromatography, and then the confirmation and quantitation are done using modern instrumental methods. However, no studies are available in the literature on drug detection in saliva, sweat and other biological materials. Therefore a suitable technique needs to be developed for its detection in biological matrices. Particularly so for a country like India, this drug abuse is constantly increasing. In this article, we deal with the chemistry, pharmodynamics, drug-herb interaction, metabolic fate (pharmokinetics), related fatalities, abuse, effects and detection methods of MEPH, to create awareness about this drug abuse in India.


Keywords


Drug Abuse, Mephedrone, Synthetic Cathinone, Traffickers.

References





DOI: https://doi.org/10.18520/cs%2Fv112%2Fi11%2F2212-2218